Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?

Jeffrey S Hoch, Jaclyn Beca, Mona Sabharwal, Scott W. Livingstone, Anthony L.A. Fields

Research output: Contribution to journalLetter

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)879-882
Number of pages4
JournalPharmacoEconomics
Volume33
Issue number8
DOIs
StatePublished - Aug 1 2015
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this